Stay updated on Tirzepatide in Obesity: SURMOUNT-1 Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in Obesity: SURMOUNT-1 Clinical Trial page.

Latest updates to the Tirzepatide in Obesity: SURMOUNT-1 Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.3.3 was added. HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedThe page now lists Revision: v3.3.2 and removes Revision: v3.3.1, indicating a small system update with no changes to trial information.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page history now shows a new revision entry v3.3.1 and the prior v3.2.0 has been removed. This metadata update does not affect study data or any visible content on the page.SummaryDifference0.1%

- Check56 days agoChange DetectedRemoved the notice about a lapse in government funding and NIH operating status from the page. This administrative message previously informed users about potential processing delays and status updates.SummaryDifference0.5%

- Check70 days agoChange DetectedThe changes appear to be limited to UI/layout of the Record History page, with no alterations to core study data or statuses. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check99 days agoChange DetectedMajor update: page version bumped to v3.2.0 and a government funding operating-status notice added; previous v3.0.2 revision removed.SummaryDifference10%

Stay in the know with updates to Tirzepatide in Obesity: SURMOUNT-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in Obesity: SURMOUNT-1 Clinical Trial page.